i3 Health

02/15/2026

February is and Cancer Awareness Month. Approximately 9,500 new patients are diagnosed with gallbladder and bile duct cancers annually in the United States.

02/14/2026

Clinical goals in are shifting toward higher protection levels to support active lifestyles. In this Satellite Symposium segment, experts review ISTH guidelines, evolving factor thresholds, and the role of novel gene therapies.

Watch here: https://www.youtube.com/watch?v=57UdlPIHHBw&t=3s

02/14/2026

Today is National Donor Day, a time to recognize the extraordinary impact of organ, eye, tissue, blood, platelet, and marrow donors. Their gifts give patients and families more time, more options, and more hope.

02/13/2026

This Multidisciplinary Task Force reviews how to use novel imaging and biomarkers for earlier diagnosis and how to tailor treatment selection from the numerous therapies currently in development.

Learn more here: https://bit.ly/3FOXB8N

02/13/2026

Richard S. Bedlack, MD, PhD, MS, Director of the Duke Health ALS Clinic, shares that he is inspired every day by the kindness, humor, and unconditional love he sees in his patients and their families. His work spans clinical care, trials, biomarker research, and leadership of the ALSUntangled program.

Learn more from Dr. Bedlack here: https://bit.ly/3KLMzE5

02/12/2026

NEW PLAYLIST - Updates: 4-Module Microlearning Series

Listen to all 4 modules featuring Dr. Christoph U. Correll → https://bit.ly/4aLQdbj

02/12/2026

Today we are revisiting a vital tip for from Sally Werner, RN, BSN, MSHA. She notes that the first step in prevention is establishing a relationship with a primary care physician to discuss specific risks like , diet, and .

These conversations are essential for creating a personalized plan. Read the full interview here: https://bit.ly/4ql7MDR

02/11/2026

Type 2 and are closely linked, share common risk factors, and are both increasing worldwide. New drugs that can address both conditions at once may transform care for people with chronic cardiometabolic disease.

This activity explores how glucose-lowering medications affect body weight, new anti-obesity treatments, and therapies that target obesity and type 2 diabetes together: https://bit.ly/4bW5PIm

02/11/2026

Your Update: Here’s what’s new!

HER2-Mutant NSCLC: Closing the Gap Between Detection and Optimal Treatment - https://bit.ly/4r2KGDf

Oncology Unfiltered: If a Patient Can’t Afford to Fill the Prescription, Is It Really a Treatment Option - https://bit.ly/4abZ5qz

02/10/2026

In this clip from our “Mission Remission” escape room, Dr. Benjamin Cohen (Cleveland Clinic) breaks down , clinical presentation, and disease characteristics, and highlights key differences from Crohn’s disease and risk stratification.

Watch the video on YouTube: https://www.youtube.com/watch?v=j_icYYIc4RE

Then complete the full escape room and claim free CME credit: https://bit.ly/4mTe7p4

Earn CME credits in this Virtual Escape Room on ulcerative colitis. Follow a patient case to explore treat-to-target strategies and advanced...

02/10/2026

For , we are exploring how care has been transformed by and targeted therapies.

In Module 1 of this activity, Michael A. Davies, MD, PhD (MD Anderson Cancer Center) reviews how to use biomarkers and treatment sequencing to optimize outcomes for individual patients: https://bit.ly/44mRcfD

02/09/2026

Discover expert-led on the i3 Health YouTube channel!

Access engaging videos on the latest advancements in cancer care, treatment strategies, and patient management. Subscribe today to stay informed and enhance your expertise: www.youtube.com/